Virtual Symposium:
Flow Cytometry & Multiplexing Tools
08 April 2021 | BST (UTC+1)

Discuss innovative applications and recent technological developments within the fields of multiplexed assays and flow cytometry

The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies to discuss the latest in multi-omic cytometry and its application in immuno-oncology and infectious diseases alongside advances in multiplexing tools for biomarker analysis. 

Download Agenda

Full details on the Symposium including the presentations, topic areas and confirmed speakers will be released in the conference brochure in the coming weeks

Book Online

Registration for Virtual Symposium: Flow Cytometry & Multiplexing Tools is now open. Please click the button below to register for this event.

LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts interested in the latest biomarker strategies and technologies 

Headline Sponsor

Thought Leaders

Business Developer Sponsor

Programme

Benefits to Attending the Virtual Symposium: Flow Cytometry & Multiplexing Tools include:

Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions working within multi-omic cytometry and its application in immuno-oncology and infectious diseases

  • Hear from and meet with the leading figures in flow cytometry and multiplexing, offering innovative case studies on the latest strategies and technologies impacting biomarker research and drug development
  • Interact with fellow attendees and speakers during the live Q&As, taking place at the end of each presentation and through our interactive panel discussions
  • Explore how companies are utilising a variety of multiplexing tools and assays to improve efficiency and capacity with case studies from a variety of therapeutic areas 
  • Gain insights into the latest applications of flow cytometry in drug development. Presentations consider the role of flow cytometry in the clinic, applications of cytometry in disease monitoring and diagnosis, and case studies from immuno-oncology and infectious disease

Agenda at a Glance

Stream 1: Latest Strategies And Technologies Progressing Flow Cytometry

  • Latest developments in flow systems 
  • Discover the current platform technologies advancing flow cytometry in single cell analysis 
  • Developing multi-parameter flow cytometry tools 
  • Challenges of multiplexed flow cytometry technologies 
  • Data management and analysis for multi-omic tools  
  • Explore the role of flow cytometry in a clinical environment
  • Applying flow cytometry in disease monitoring and diagnosis 
  • Case studies: flow cytometry applications within Immuno-Oncology and Infectious Disease 

Stream TwoMultiplexing Tools & Technologies For Biomarker Analysis

  • Multiplex biomarker imaging 
  • Multiplexed biomarker methods in Alzheimer’s Disease, Oncology, Infectious Disease and Kidney Diseases 
  • Multiplexed laboratory and clinical assays 
  • Multiplexed immunoassays for the successful scale up of translational research through rapid and reproducible biomarker qualification 

Confirmed Speakers

The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future

Previous speakers at 2020’s Biomarkers Series UK included

Graham Pockley, NTU

Graham Pockley

Nottingham Trent University

Ruth Barnard, GSK

Ruth Barnard

GlaxoSmithKline 

emilyanne

Emilyanne Leonard

AstraZeneca 

Axel Ducret, F. Hoffman-La Roche Ltd.

Axel Ducret

F. Hoffman-La Roche Ltd. 

Vipul Baxi, Bristol-Myers Squibb

Vipul Baxi

Bristol-Myers Squibb 

Darrell Borger

Darrell Borger

Takeda

Event Features​

Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences. 

Virtual Presentations

Benefit from the insight of our expert speakers via live and pre-recorded presentations

Live Q&As

Interact with fellow attendees and speakers during the live Q&As at the end of each presentation

Digital Networking Opportunities

Connect directly with other registrants of event around the world

Luminex

Headline Sponsor

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer flexible solutions for hospitals, reference labs, and researchers, as well as innovative xMAP® and flow cytometry solutions that span a wide variety of applications, including molecular diagnostics, drug discovery, life science research, immunology, and personalized medicine. For further information, please visit luminexcorp.com.

Eurofins Discovery

Thought Leader

Eurofins Discovery supports Drug Discovery through the combined expertise of Cerep, DiscoverX, Panlabs, Villapharma, and Selcia Drug Discovery. We offer a broad portfolio including medicinal and synthetic chemistry, in vitro pharmacology products and services, cell-based phenotypic assays, ADME-Tox, in vivo drug safety and efficacy, custom proteins, and assay development services. Eurofins Discovery provides the experience, depth, breadth, and innovative testing services and product tools to support researchers in their endeavors to accelerate the discovery and development of candidate molecules.

Eurofins DiscoverX, the Eurofins Discovery products company, is the trusted products solutions provider enabling scientists from drug discovery to post-market validation. Offering the most comprehensive portfolio of biologically-relevant and qualified cell-based assays, stable cell lines, and optimized reagents across the major therapeutic targets, confidently accelerate your biologics and small molecule drug discovery programs today.

NeoGenomics

Thought Leader

NeoGenomics is an industry-leading cancer diagnostics and pharma services company. We enable advanced oncology patient care leveraging the most extensive diagnostic solid tumor and hematological test menus, sub-specialized pathology, and expertise in biomarker development. We partner closely with our pharma and research clients to meet program objectives and delivery from biomarker discovery through CDx validation and commercialization.

Ultivue

Business Developer Sponsor